Results 91 to 100 of about 210,681 (329)

Long‐Term Outcomes of Cardiac Resynchronization Therapy Using Apical Versus Nonapical Left Ventricular Pacing

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background Experimental evidence indicates that left ventricular (LV) apical pacing is hemodynamically superior to nonapical LV pacing. Some studies have shown that an LV apical lead position is unfavorable in cardiac resynchronization therapy. We sought
Francisco Leyva, Abbasin Zegard, Robin J. Taylor, Paul W. X. Foley, Fraz Umar, Kiran Patel, Jonathan Panting, Peter van Dam, Frits W. Prinzen, Howard Marshall, Tian Qiu   +10 more
doaj   +1 more source

Electrocardiographic imaging for cardiac arrhythmias and resynchronization therapy

Europace, 2020
Use of the 12-lead electrocardiogram (ECG) is fundamental for the assessment of heart disease, including arrhythmias, but cannot always reveal the underlying mechanism or the location of the arrhythmia origin. Electrocardiographic imaging (ECGi) is a non-
Hélder Pereira, S. Niederer, C. Rinaldi
semanticscholar   +1 more source

Left Ventricular Pacing In Patients With Congestive Heart Failure [PDF]

, 2006
Cardiac resynchronisation therapy (CRT) using biventricular (BIV) pacing has proved its effectiveness to correct myocardial asynchrony and improve clinical status of patients with severe congestive heart failure (CHF) and widened QRS. Despite a different
Etienne, Yves, Jean-Jacques, Blanc, Marjaneh, Fatemi   +2 more
core   +2 more sources

The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial [PDF]

, 2008
Aims: Cardiac dyssynchrony is common in patients with heart failure, whether or not they have ischaemic heart disease (IHD). The effect of the underlying cause of cardiac dysfunction on the response to cardiac resynchronization therapy (CRT) is unknown ...
Andren, B, Blomstrom, P, Blomstrom-Lundqvist, C, CARE-HF Study Investigators,, Cleland, JGF, Freemantle, N, Lonnerholm, S, Remp, T, Wikstrom, G   +8 more
core   +2 more sources

The role of cardiac acoustic biomarkers in monitoring patients with heart failure: A systematic literature review

ESC Heart Failure, Volume 12, Issue 2, Page 980-997, April 2025.
Abstract Heart failure (HF) creates a considerable clinical, humanistic and economic burden on patients and caregivers as well as on healthcare systems. To attenuate the significant burden of HF, there is a need for enhanced management of patients with HF.
Javed Butler, Malcolm Brown, Philippe Prokocimer, Ashley C. Humphries, Sophie Pope, Olivia Wright, Jun Su, Osama Elnawasany, Bogdan Muresan   +8 more
wiley   +1 more source

2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.

European Heart Journal, 2021
M. Glikson, J. C. Nielsen, M. Kronborg, Y. Michowitz, Angelo Auricchio, I. Barbash, J. Barrabés, G. Boriani, F. Braunschweig, Michele Brignole, H. Burri, A. Coats, J. Deharo, V. Delgado, G. Diller, Carsten W Israel, Andre Keren, R. Knops, D. Kotecha, C. Leclercq, B. Merkely, Christoph Starck, I. Thylén, J. Tolosana   +23 more
semanticscholar   +2 more sources

Beta Blockers Up-Titration in Patients with Heart Failure Reduced Ejection Fraction and Cardiac Resynchronization Therapy, a Single Center Study

Medical Sciences, 2019
Clinical trials have shown the benefits of β-blockers therapy in patients with heart failure reduced ejection fraction. These benefits include improved survival and a reduced need for hospitalization. Cardiac resynchronization therapy has emerged as
Daniele Masarone, Marina Verrengia, Ernesto Ammendola, Rita Gravino, Fabio Valente, Rossella Vastarella, Marta Rubino, Giuseppe Limongelli, Giuseppe Pacileo   +8 more
doaj   +1 more source

Reversible left bundle branch block should be mentioned in cardiac resynchronization therapy; A clinical case report

ARYA Atherosclerosis, 2016
BACKGROUND: Cardiac resynchronization therapy (CRT) is a medical device to help cardiac synchronized contractility by electrical impulses. Improvement of symptoms and left ventricular systolic function, reducing hospital admissions and mortality in ...
Ali Vasheghani-Farahani, Masih Tajdini, Seyed Abolfazl Mohsenizadeh, Seyed Mohammad Reza Hosseini   +3 more
doaj  

Effect of cardiac resynchronization therapy on right ventricular function [PDF]

, 2016
Cardiolog
Bax, Jerome J., Garg, Akash, Goel, Sunny, Lavie, Carl, Lazar, Jason M., Lichstein, Edgar, Mukherjee, Debabrata, Sharma, Abhishek, Vallakati, Ajay   +8 more
core   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source